Potential Therapeutic Targets for Luminal Androgen Receptor Breast Cancer: What We Know so Far
Sign Up to like & getrecommendations! Published in 2023 at "OncoTargets and Therapy"
DOI: 10.2147/ott.s379867
Abstract: Abstract Luminal Androgen Receptor Breast Cancers (LAR BCs) are characterized by a triple negative phenotype and by the expression of Androgen Receptor (AR), coupled with luminal-like genomic features. This unique BC subtype, accounting for about… read more here.
Keywords: receptor breast; lar bcs; androgen receptor; androgen ... See more keywords